Christine Ann Miller
LIFE SCIENCES EXECUTIVE
Christine Ann Miller is a life sciences executive who most recently served as President and CEO of Melinta Therapeutics, where she led a significant transformation of the company into a leading player in the hospital acute care market. When Ms. Miller stepped into the role, Melinta was a pure-play antibiotics business facing industry headwinds. Under her leadership, the company evolved into a more diversified and resilient organization, doubling its revenue, securing multiple FDA approvals, and expanding its portfolio through a combination of licensing and acquisitions. She also guided the business to sustainable profitability while strengthening operational discipline and execution, ultimately positioning Melinta for a successful strategic acquisition in August 2025.
Ms. Miller is known for her people-first leadership philosophy, grounded in the belief that strong performance follows strong teams. She focuses on building organizations where accountability, clarity, and collaboration are embedded into how work gets done. Her leadership style emphasizes aligning teams around shared goals while empowering individuals to operate with ownership and purpose, enabling organizations to navigate complexity and deliver meaningful, measurable results.
Prior to Melinta, Ms. Miller held senior global leadership roles at Sandoz, Actavis, and Merck, where she led large-scale portfolio transformations, executed product launches, and drove growth initiatives across both branded and generic pharmaceutical businesses. Her experience spans commercial strategy, operations, and enterprise leadership, giving her a comprehensive perspective on how to build, scale, and evolve healthcare organizations in dynamic markets.
In addition to her executive leadership experience, Ms. Miller has served on both private and public company boards, as well as nonprofit boards, including Iveric Bio, BioNJ, and the Antimicrobials Working Group, along with advisory roles with the Healthcare Businesswomen’s Association and the Lighthouse Guild. Through these roles, she provides strategic, operational, and governance oversight while contributing to broader industry advancement and the development of future leaders in life sciences.
Ms. Miller holds an MBA and Master’s in Technology Management from Stevens Institute of Technology and a B.S. in Chemical Engineering from Rensselaer Polytechnic Institute.
